Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2, a minor maintenance change with no substantive study content altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner about government funding lapse and operating status; no study data or links were changed.SummaryDifference0.4%

- Check33 days agoChange DetectedArms B and C are closed to enrollment, and Arm A remains open for enrollment.SummaryDifference0.4%

- Check62 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check69 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to core content or functionality based on the provided additions/deletions.SummaryDifference0.1%

- Check83 days agoChange DetectedVersion bumped to v3.0.2; previous revision v3.0.1 removed and Back to Top element deleted.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.